Resverlogix Corp.



September 25, 2015: Resverlogix clinical and science teams, along with two members of the international clinical steering committee for the upcoming BETonMACE study, presented a Research and Development Update for RVX-208 "apabetalone" on September 25, 2015 in New York City. Please access the replay here: 

Sept. 10, 2015: Donald McCaffrey presented at the Rodman & Renshaw 17th Annual Global Investment Conference. Link to presentation:

At the Rodman & Renshaw conference, Mr. McCaffrey also had the opportunity to speak with Stock News Now (SNN). The video interview can be accessed here:

Resverlogix in the Media

Aug. 26, 2015: Resverlogix featured in the Life Sciences Report: Disrupting Treatment of Cardiovascular Disease with Epigenetics: Resverlogix CEO Donald McCaffrey. Access article here: /upload/media_element/218/01/donald-mccaffrey-lsr-interview-8-26-15.pdf

June 25, 2015: Resverlogix’s Dr. Ewelina Kulikowski has written and published an article for the summer 2015 issue of the European Biopharmaceutical Review (EBR) titled, “New Direction.” Access article here: 

April 22, 2015: Donald McCaffrey, President & CEO on BNN’s Business Day

April 27, 2015- BioCentury: Hepalink gains rights to Resverlogix’s RVX-208 in China. Link here:

April 28, 2015- BioWorld Today: Phase III Starting Soon. Resverlogix getting specific: With potential $400M BET, Hepalink licensing accord, by Randy Osborne. Link here to access the full article.

April 28, 2015- Bloomberg Business: Resverlogix in Discussions to Be Bought, by Eric Lam. Link here:

April 28, 2015- BioSpace Breaking News: Resverlogix (RVX.TO) CEO Says It’s in Talks With Suitors, After $100M in Q1 Deals, by Riley McDermid. Link here:

April 28, 2015- Fierce Biotech: Resverlogix gets a $116M China Drug development deal, stokes buyout buzz, by John Carroll. Link here:

April 28, 2015 - GEN News Highlights: Hepalink Buys China-Area Rights to Resverlogix's CV Candidate for Up-to-$441.5M Link here:

Events - Q4 2015

Resverlogix will be attending several key industry conferences. Not all events offer a presentation opportunity. Please note this list is not exhaustive and subject to change.

Oct. 20-21: Bio Investor Forum, San Francisco, CA

Oct. 25-28: Cavendish Global Health Impact Forum, Cleveland, OH

Oct. 26-28: BioNetwork, Laguna Nigel, CA

Nov. 2-4: Bio-Europe 2015, Munich, Germany

Nov. 3-8: ASN Kidney Week, San Diego, CA

Nov. 5-7: CTAD 2015, Barcelona, Spain

Nov. 7-11: AHA Conference 2015, Orlando, FL

Nov. 30 – Dec. 4: IDF 2015, Vancouver, BC

To arrange a meeting with senior management, please contact Sarah Zapotichny, Director of Investor Relations & Corporate Communications at